Medicine and Dentistry
Prostate Specific Membrane Antigen
100%
Gallium 68
100%
Positron Emission Tomography-Computed Tomography
82%
Prostate Cancer
75%
Antigen
48%
Prostatectomy
24%
Biochemical Recurrence
16%
Prostate Specific Antigen
14%
Anal Fistula
14%
Escherichia coli
14%
Intervertebral Disk Degeneration
14%
Distant Metastasis
14%
Abscess
14%
Lymph Node Metastasis
14%
PARP Inhibitor
14%
Cas9
14%
Clustered Regularly Interspaced Short Palindromic Repeat
14%
Recurrence Risk
14%
Serositis
11%
Conventional Imaging
10%
Esophagus
9%
Disease
7%
Castration Resistant Prostate Cancer
7%
PARP1
7%
Recurrent Disease
6%
Autophagy
5%
Keyphrases
Primary Staging
15%
Periappendicular Abscess
14%
Radical Prostatectomy
14%
High-grade Prostate Cancer
14%
Positron Emission Tomography-computed Tomography (PET-CT)
14%
Prostate-specific Antigen
14%
Recurrence Rate
14%
Conventional Imaging
10%
Prostate Cancer Patients
6%
Biochemistry, Genetics and Molecular Biology
Poly ADP Ribose Polymerase
14%
Circular RNA
14%
CRISPR/Cas9
14%
Poly ADP Ribose Polymerase
14%
PARP1
8%
Autophagy
6%